1. Long-acting insulin analogs and cancer
    L. Sciacca et al, 2018, Nutrition, Metabolism and Cardiovascular Diseases CrossRef
  2. Insulin/IGF-1 enhances intestinal epithelial crypt proliferation through PI3K/Akt, and not ERK signaling in obese humans
    Weinan Zhou et al, 2018, Exp Biol Med (Maywood) CrossRef
  3. Distinct role of autophagy on angiogenesis: highlights on the effect of autophagy in endothelial lineage and progenitor cells
    Mehdi Hassanpour et al, 2018, Stem Cell Res Ther CrossRef
  4. Short-term adverse effects of anticancer drugs in patients with type 2 diabetes
    Agostino Milluzzo et al, 2019, Journal of Chemotherapy CrossRef
  5. Identification of highly potent and selective MMP2 inhibitors addressing the S1’ subsite with D-proline-based compounds
    Elena Lenci et al, 2019, Bioorganic & Medicinal Chemistry CrossRef
  6. The Influence of Curcumin on the Downregulation of MYC, Insulin and IGF-1 Receptors: A possible Mechanism Underlying the Anti-Growth and Anti-Migration in Chemoresistant Colorectal Cancer Cells
    Seyed Ahmad Hosseini et al, 2019, Medicina CrossRef
  7. Knockdown of long non-coding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p
    An-Quan Shang et al, 2019, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
  8. Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation
    Aviva Rabin-Court et al, 2019, PLoS ONE CrossRef
  9. Obesity, Insulin Resistance, and Colorectal Cancer: Could miRNA Dysregulation Play a Role?
    Francesca Cirillo et al, 2019, IJMS CrossRef
  10. Mathematical morphology-based imaging of gastrointestinal cancer cell motility and 5-aminolevulinic acid-induced fluorescence
    Rima Ramonaite et al, 2019 CrossRef
  11. Review: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications
    Iliana C Lega et al, 2020 CrossRef
  12. Insulin receptor substrate-4 interacts with ubiquitin-specific protease 18 to activate the Jak/STAT signaling pathway
    Baihai Jiao et al, 2017, Oncotarget CrossRef
  13. Diabetes mellitus is associated with liver metastasis of colorectal cancer through production of biglycan-rich cancer stroma
    Rina Fujiwara-Tani et al, 2020, Oncotarget CrossRef
  14. YAP mediates the interaction between the Hippo and PI3K/Akt pathways in mesangial cell proliferation in diabetic nephropathy.
    Xuan Qian et al, 2021, Acta Diabetol CrossRef
  15. Proteomic Analysis of Protein Ubiquitination Events in Human Primary and Metastatic Colon Adenocarcinoma Tissues
    Yi Zhang et al, 2020, Front. Oncol. CrossRef
  16. Night-Shift Work Duration and Risk of Colorectal Cancer According to IRS1 and IRS2 Expression
    Yan Shi et al, 2020, Cancer Epidemiol Biomarkers Prev CrossRef
  17. Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy
    Alejandro Schcolnik-Cabrera et al, 2021, Sci Rep CrossRef
  18. Association Between Triglyceride Glucose Index and Non-Small Cell Lung Cancer Risk in Chinese Population
    Xin Yan et al, 2021, Front. Oncol. CrossRef
  19. Targeting obesity-related dysfunction in hormonally driven cancers
    Maria M. Rubinstein et al, 2021, Br J Cancer CrossRef
  20. null
    Kumari Sunita Prajapati et al, 2021 CrossRef
  21. Targeting Adipokines in Obesity-Related Tumors
    Xi Pu et al, 2021, Front. Oncol. CrossRef
  22. Fasting blood glucose was linearly associated with colorectal cancer risk in the population without self-reported diabetes mellitus history
    Jingjing Wu et al, 2021 CrossRef
  23. Metabolic Hormones Modulate Macrophage Inflammatory Responses
    Matthew J. Batty et al, 2021, Cancers CrossRef
  24. Diabetes Mellitus and Obesity as Risk Factors for Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis
    Yu Lu et al, 2021, Front. Endocrinol. CrossRef
  25. Insulin-induced palmitoylation regulates the Cardiac Na+/Ca2+ Exchanger NCX1
    Caglar Gök et al, 2022, Cell Calcium CrossRef
  26. Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells
    Domenica Scordamaglia et al, 2022, J Transl Med CrossRef
  27. Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer.
    Yuanyuan Chen et al, 2022, BMC Cancer CrossRef
  28. Acromegaly and Colorectal Neoplasm: An Update
    Leandro Kasuki et al, 2022, Front. Endocrinol. CrossRef
  29. Obesity: a perfect storm for carcinogenesis
    Benjamin H. L. Harris et al, 2022, Cancer Metastasis Rev CrossRef
  30. Association between triglyceride glucose index and risk of cancer: A meta-analysis
    Huan Wang et al, 2023, Front. Endocrinol. CrossRef
  31. The Insulin Receptor Substrate 2 Mediates the Action of Insulin on HeLa Cell Migration via the PI3K/Akt Signaling Pathway
    Anabel Martínez Báez et al, 2023, CIMB CrossRef
  32. Decoding the role of leptin and adiponectin in obesity-related gastrointestinal cancer
    Vanda Marques et al, 2023 CrossRef
  33. Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia
    Davide Viggiano, 2023, JCM CrossRef
  34. The strategic involvement of IRS in cancer progression
    Mehnaz Ahmed et al, 2023, Biochemical and Biophysical Research Communications CrossRef
  35. Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder Cancer with High Epithelial–Mesenchymal Transition and Stemness Properties
    Feng-Che Kuan et al, 2023, IJMS CrossRef
  36. Molecular Mechanism of Salvia miltiorrhiza in the Treatment of Colorectal Cancer Based on Network Pharmacology and Molecular Docking Technology
    Yi-Ling Jiang et al, 2024, DDDT CrossRef
  37. Arginase-induced cell death pathways and metabolic changes in cancer cells are not altered by insulin
    Hui Yi Chew et al, 2024, Sci Rep CrossRef
  38. Association between metabolic syndrome and the risk of colorectal cancer: a prospective study in China
    zhongge Wang et al, 2023 CrossRef